MaxCyte
MXCT
#7209
Rank
$0.34 B
Marketcap
$3.23
Share price
-5.56%
Change (1 day)
-22.17%
Change (1 year)

Operating Margin for MaxCyte (MXCT)

Operating Margin as of November 2024 (TTM): -77.97%

According to MaxCyte's latest financial reports and stock price the company's current Operating Margin is -77.97%. At the end of 2023 the company had an Operating Margin of -91.85%.

Operating Margin history for MaxCyte from 2021 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-91.85%72.47%
2022-53.25%-5.41%
2021-56.30%24.68%
2020-45.15%-24.29%
2019-59.64%12.08%
2018-53.21%-24.96%
2017-70.91%160.07%
2016-27.27%75.25%
2015-15.56%-39.32%
2014-25.64%82.1%
2013-14.08%-64.17%
2012-39.30%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.